Cureline is Your Global Human Biospecimens Biotech Expert
Cureline is a global human biospecimens biotech company and CRO providing effective solutions for scientific, clinical research projects and support for drug development. We have more than 10 years of experience in tissue biobanking and we are specializing in precision medicine and human tissue research projects. We have extensive expertise in human specimen collection, analysis, biobanking, study design, regulatory affairs and clinical network management.
Our global capabilities include collaborations and on-going projects with over 90 clinical and scientific centers in 15 countries around the world. We collaborate with major clinical centers in Europe, Asia, and the USA and maintain an extensive biorepository of human biospecimens at our core Cureline laboratories at South San Francisco.
Our expertise include human primary specimen collection for biomarkers research, molecular diagnostics, and drug development programs. We are working with a number of academic institutions, biotech and pharmaceutical companies around the world who have research and clinical programs in hematology, oncology, CNS disorders, inflammatory and cardiovascular diseases, infectious diseases, and other clinical indications.
Our translational histology division is a CLIA, GLP laboratory that provides high-end tissue research services to the biomedical research community including IHC protocol development, clinical specimens processing and diagnostics, digital pathology, among others.
Cureline, Inc., is a global human biospecimens biotech company and CRO specializing in human biospecimen procurement, human processing and analysis.
Wide range of clinically annotated human biospecimens from various therapeutic areas. Human tissue samples in FF and FFPE format.
High-end tissue research services including IHC protocol development, clinical specimens processing and diagnostics, and digital pathology.
Regulatory affairs, patient enrollment/retention, clinical site relation management, and research for new therapies /diagnostic products for distribution in Russia.